|
MAD2L1BP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.365400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.255400E-03 |
| Normal-vs-Stage2 |
5.177000E-01 |
| Normal-vs-Stage3 |
2.331000E-01 |
| Normal-vs-Stage4 |
8.839000E-01 |
| Stage1-vs-Stage2 |
2.613200E-01 |
| Stage1-vs-Stage3 |
1.203430E-01 |
| Stage1-vs-Stage4 |
2.005800E-01 |
| Stage2-vs-Stage3 |
5.977800E-01 |
| Stage2-vs-Stage4 |
6.173200E-01 |
| Stage3-vs-Stage4 |
2.938800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.141200E-01 |
| Normal-vs-AfricanAmerican |
3.370400E-01 |
| Normal-vs-Asian |
5.994400E-01 |
| Caucasian-vs-AfricanAmerican |
2.897200E-01 |
| Caucasian-vs-Asian |
5.726400E-01 |
| AfricanAmerican-vs-Asian |
7.589600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.055200E-01 |
| Normal-vs-Female |
6.403200E-01 |
| Male-vs-Female |
9.531200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.103640E-01 |
| Normal-vs-Extreme_Weight |
6.565600E-01 |
| Normal-vs-Obese |
3.852400E-01 |
| Normal-vs-Extreme_Obese |
6.299400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.907200E-01 |
| Normal_Weight-vs-Obese |
9.111500E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.279000E-01 |
| Extreme_Weight-vs-Obese |
3.403800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.087800E-01 |
| Obese-vs-Extreme_Obese |
5.118800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.191600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.543800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.712400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.027200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.472200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.654400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.338500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.009600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.774000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.006440E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.609400E-01 |
| Normal-VS-Type2 PRCC |
1.619020E-01 |
| Normal-VS-KIRP CIMP |
2.737000E-01 |
| Normal-VS-Unclassified PRCC |
1.804500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.048400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.878600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.504200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.054400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.328000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.309990E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.754200E-01 |
| Normal-vs-N1 |
2.041200E-01 |
| Normal-vs-N2 |
6.36889999960921E-07 |
| N0-vs-N1 |
2.317800E-01 |
| N0-vs-N2 |
5.156200E-03 |
| N1-vs-N2 |
5.174400E-02 |
|
|
